Namely, AM1241 significantly increased CB2R expression and up-regulated Parkin/PINK1 and PI3K/AKT, much higher than that of normal controls, which finally alleviate PD symptoms in MPTP-treated mice. This evidence concerns the gene PINK1 and Parkinson disease.